Step Named to Fast Company’s List of the World’s Most Innovative Companies for 2022
Step joins the ranks of legendary companies like SpaceX, Shopify, Snap and more. PALO ALTO,…
News
ABBYY Strengthens Partner Ecosystem with ABBYYOne, a New Global Program to Drive Intelligent Process Automation (IPA)
CHARLOTTE, N.C.–(BUSINESS WIRE)–#ABBYYOne–ABBYY launched its new global partner program, ABBYYOne, to enable partners to accelerate…
Ryder to Reshape Inbound Supply Chain for Southern Glazer’s Wine & Spirits
The largest distributor of beverage alcohol in North America turns to Ryder’s supply chain team…
Google to Acquire Mandiant
Acquisition to bring Google speed and scale to Mandiant’s unparalleled intelligence and expertise – at…
United States DoD Artificial Intelligence: Computing Power and AI Advancements Ensure Broad and Effective Defense Capabilities – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “United States DoD Artificial Intelligence Growth Opportunities” report has been added to ResearchAndMarkets.com’s…
Seeking a high-growth career in tech? Data Center Career Pathfinder makes it easier with help from Google, Meta, and Microsoft
The first comprehensive taxonomy of digital infrastructure job roles launches to help expand and diversify…
Go!Foton To Announce EKO Product Availability, Enhancements At OFC
SAN DIEGO–(BUSINESS WIRE)–Go!Foton, a world leader in optical components and connectivity solutions for carriers and…
NEC OncoImmunity Acquires VAXIMM’s Neoantigen Vaccine Development Assets
VAXIMM technology enables fast generation and delivery of personalized T-cell cancer vaccines and may overcome…
Inventiva announces that its IND application for the Phase II combination trial with lanifibranor and empagliflozin in patients with NASH and T2D has been accepted by the FDA
FDA assessment concludes that the Phase II combination trial, LEGEND, may proceed The initiation of…
Basilea reports preclinical data on anti-cancer activity of novel oncology drug candidate BAL0891 at ESMO TAT congress
Press Release Basel, Switzerland, March 08, 2022 Basilea Pharmaceutica Ltd. (SIX: BSLN), a commercial-stage biopharmaceutical…
Voyager Therapeutics Announces License Option Agreement with Novartis for Target-Specific Access to Next-Generation TRACER™ AAV Capsids for Gene Therapy Programs
Voyager receives $54 million upfront with potential option exercise fees and milestone payments of up…
HIVE Blockchain Provides Update on February 2022 Production and At-The-Market Offering and Conclusion of Canadian At-The-Market Offering
This news release constitutes a “designated news release” for the purposes of the Company’s prospectus…
Provenir Appoints Francisco Franch to Lead Expansion in Spain
Demand for company’s AI-powered risk decisioning software continues to drive global expansion PARSIPPANY, N.J.–(BUSINESS WIRE)–#AI—Provenir,…
Parallelle Finance Introduces the Parallelle Finance Gender Lens Scorecard
SEATTLE–(BUSINESS WIRE)–Parallelle Finance, a research, analysis, and advocacy firm focusing on gender lens equity and…
Phison Strengthens its Position in Automotive Storage Market: Secures Automotive Functional Safety Certification ISO 26262
Functional Safety Certification Enables the Company to Develop System-Critical Automobile Storage Solutions for Driverless Cars…
Zylpha Announces 2022 ‘Legal Innovation Award’ Winners
Leading UK Legal systems developer Zylpha (www.zylpha.com) has announced the winners of its annual ‘Legal…
Appear makes US debut at NAB 2022
Alongside launching North America operations, Appear expands its NEO Series offering with the release of…
Keynote 2022: myWorld presents its newest products and shopping innovations
The first myWorld Keynote of the year took place on the 5th of March in…
Roche to present new Evrysdi data at MDA 2022 and highlight expanding neuromuscular disease portfolio
Evrysdi® (risdiplam) data further confirm long-term efficacy and safety data in a broad range of…
Valneva Successfully Completes Pivotal Phase 3 Trial of Single-Shot Chikungunya Vaccine Candidate
VLA1553-301 six-month follow-up completed – all endpoints met Seroprotection (protective CHIKV neutralizing antibody levels) in…